Overview of Reproductive, Maternal, Newborn, and Child Health
MNCH encompasses health problems across the life course from adolescent girls and women before and during pregnancy and delivery, to newborns and children. A continued focus on RMNCH is needed to address the remaining considerable burden of disease in LMICs from unwanted pregnancies; high maternal, newborn, and child mortality and stillbirths; high rates of undernutrition; frequent communicable and noncommunicable diseases; and loss of human capacity. Continue reading Overview of Reproductive, Maternal, Newborn, and Child Health
Rotavirus: Treatment, Management and Complications
Tests and Diagnostics Rotavirus is clinically indistinguishable from diarrheal diseases caused by other gastrointestinal pathogens such as noroviruses, enteric adenoviruses, astroviruses, Escherichia coli, and Salmonella. In most cases, no additional evaluation is necessary beyond history and physical exam. Findings that … Continue reading Rotavirus: Treatment, Management and Complications
Rotavirus: Cause, Epidemiology and Symptoms
Rotavirus is the leading cause of severe gastroenteritis in children less than 5 years of age. Despite the availability of a vaccine against rotavirus, it continues to result in more than 200,000 deaths worldwide per year. In developed countries with routine vaccination programs, rotavirus infection is less prevalent than in non-developed countries. Continue reading Rotavirus: Cause, Epidemiology and Symptoms
AEFI: Definitions of Terms
These are the definitions of terms that are used in relation to adverse event following immunisation (AEFI). Adverse event following immunisation (AEFI): Any untoward medical occurrence which follows immunisation and which does not necessarily have a causal relationship with the … Continue reading AEFI: Definitions of Terms
Human Papillomavirus (HPV) Vaccine
The 9-valent human papillomavirus (HPV) vaccine (9vHPV) is a second-generation, non-infectious, recombinant, 9-valent vaccine indicated to prevent diseases and cancers caused by both low-risk and high-risk human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 45, 52, 58. HPVs are the number one sexually transmitted viruses causing precancerous and cancerous lesions. Continue reading Human Papillomavirus (HPV) Vaccine
Vaccine-Preventable Diseases
From the World Health Organisation Under ‘Available vaccines’ is a list of certain diseases for which vaccines are available. For each disease or pathogen, a link is provided to a webpage with summary information on internationally available vaccines and WHO … Continue reading Vaccine-Preventable Diseases
Vaccines, Vaccination and Immunisation
Introduction Immunization is a successful use of immunotherapy to treat many infectious diseases by stimulating the immune system to produce specific antibodies or specific lymphocytes to fight off pathogens and, more recently, protect against malignant tumors. This immunotherapy creates an … Continue reading Vaccines, Vaccination and Immunisation
Priority Area One Under National Strategic Health Development Plan: Leadership and governance
Governance in health is being increasingly regarded as a salient theme on the development agenda. Leadership and governance in building a health system involve ensuring that strategic policy frameworks exist and are combined with effective oversight, coalition-building, regulation, attention to system design and accountability. Continue reading Priority Area One Under National Strategic Health Development Plan: Leadership and governance
Second National Strategic Health Development Plan 2018-2022: Forewords
The Government of the Federal Republic of Nigeria, through the Federal Ministry of Health, led the development of the first National Strategic Health Development Plan 2010-2015. The development of the Plan involved active participation of national, subnational and international stakeholders. … Continue reading Second National Strategic Health Development Plan 2018-2022: Forewords